Homocysteine and cognitive impairment: Relation with diagnosis and neuropsychological performance

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 6, 2008, Pages 506-512

  Sala, Isabel ^a   Belén Sánchez Saudinós, María ^a   Molina Porcel, Laura ^a   Lázaro, Estela ^a   Gich, Ignasi ^a   Clarimón, Jordi ^a   Blanco Vaca, Francisco ^a   Blesa, Rafael ^a   Gómez Isla, Teresa ^a   Lleó, Alberto ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Alzheimer's disease; Dementia; Folate; Homocysteine; Neuropsychological performance; Visuoconstructional functions; Vitamin B12

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ALZHEIMER DISEASE; APTITUDE TEST; ARTICLE; ATTENTION; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; MOTOR PERFORMANCE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SUBJECTIVE MEMORY COMPLAINT;

ACTIVITIES OF DAILY LIVING; AGED; BIOLOGICAL MARKERS; COGNITION DISORDERS; DEPRESSION; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 56349151931     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173710     Document Type: Article

References (71)

1. Fanapour PC, Yug B, Kochar MS: Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ 1999;98:51-54.
2. Prasad K: Homocysteine, a risk factor for cardiovascular disease. Int J Angiol 1999;8:76-86.
3. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-138.
4. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
5. Bertsch T, Mielke O, Holy S, Zimmer W, Casarin W, Aufenanger J, Walter S, Muehlhauser F, Kuehl S, Ragoschke A, Fassbender K: Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 2001;39:721-724.
6. Lehmann M, Gottfries CG, Regland B: Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord 1999;10:12-20.
7. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Hyperhomocysteinemia associated with poor recall in the third national health and nutrition examination survey. Am J Clin Nutr 2001;73:927-933.
8. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
9. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C: Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-313.
10. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
11. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM: Total homocysteine and cognitive decline in a communi tybased sample of elderly subjects: the Rotterdam study. Am J Epidemiol 1999;150:283-289.
12. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R: Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004;62:1972-1976.
13. Riggs KM, Spiro A 3rd, Tucker K, Rush D: Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the normative aging study. Am J Clin Nutr 1996;63:306-314.
14. Miller JW: Homocysteine and Alzheimer's disease. Nutr Rev 1999;57:126-129.
15. Stewart R, Asonganyi B, Sherwood R: Plasma homocysteine and cognitive impairment in an older British African-Caribbean population. J Am Geriatr Soc 2002;50:1227-1232.
16. Sachdev PS, Valenzuela MJ, Brodaty H, Wang XL, Looi J, Lorentz L, Howard L, Jones M, Zagami AS, Gillies D, Wilcken DE: Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord 2003;15:155-162.
17. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E: Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003;77:668-673.
18. Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B, Stepien K, Golebiowski M, Winblad B, Barcikowska M: Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16:64-70.
19. Ravaglia G, Forti P, Maioli F, Scali RC, Saccheitti L, Talerico T, Mantovani V, Bianchin M: Homocysteine and cognitive performance in healthy elderly subjects. Arch Gerontol Geriatr Suppl 2004;9:349-357.
20. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U: Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004;80:114-122.
21. Ellinson M, Thomas J, Patterson A: A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 2004;17:371-383, quiz 385-377.
22. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS: Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 2005;53:381-388.
23. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F: Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005;82:636-643.
24. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A 3rd: High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005;82:627-635.
25. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Tettamanti M, Lucca U: Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 2005;43:1096-1100.
26. Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RG, de Craen AJ: Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: The Leiden 85-Plus Study. Am J Clin Nutr 2005;82:866-871.
27. Annerbo S, Wahlund LO, Lokk J: The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients. Dement Geriatr Cogn Disord 2005;20:209-214.
28. Adunsky A, Arinzon Z, Fidelman Z, Krasniansky I, Arad M, Gepstein R: Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study. Arch Gerontol Geriatr 2005;40:129-138.
29. Dimopoulos N, Piperi C, Salonicioti A, Psarra V, Gazi F, Nounopoulos C, Lea RW, Kalofoutis A: Association of cognitive impairment with plasma levels of folate, vitamin B12 and homocysteine in the elderly. In Vivo 2006;20:895-899.
30. Nilsson K, Gustafson L, Hultberg B: Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease. Dement Geriatr Cogn Disord 2007;23:321-326.
31. Kim J, Park MH, Kim E, Han C, Jo SA, Jo I: Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. J Nutr 2007;137:2093-2097.
32. Clarke R: Homocysteine-lowering vitamin B supplements do not improve cognitive performance in healthy older adults after two years. Evid Based Ment Health 2007;10:27.
33. Goodwin JS, Goodwin JM, Garry PJ: Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249:2917-2921.
34. Lindeman RD, Romero LJ, Koehler KM, Liang HC, LaRue A, Baumgartner RN, Garry PJ: Serum vitamin B12, C and folate concentrations in the New Mexico elder health survey: correlations with cognitive and affective functions. J Am Coll Nutr 2000;19:68-76.
35. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, Seeman TE: Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: Macarthur Studies of Successful Aging. Am J Med 2005;118:161-167.
36. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL: Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology 2004;63:254-260.
37. Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bottiglieri T: Association of homocysteine with plasma amyloid-β protein in aging and neurodegenerative disease. Neurology 2005;65:1402-1408.
38. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
39. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-944.
40. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
41. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
42. Blesa R, Pujol M, Aguilar M, Santacruz P, Bertran-Serra I, Hernandez G, Sol JM, Pena-Casanova J: Clinical validity of the 'Mini-Mental State' for Spanish speaking communities. Neuropsychologia 2001;39:1150-1157.
43. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
44. Wechsler D: Wechsler Memory Test: Administration and Scoring Manual. San Antonio, The Psychological Corporation, 1997.
45. Buschke H, Fuld PA: Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-1025.
46. Benton A: A Visual Retention Test for Clinical Use. New York, Psychological Corporation, 1946.
47. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The consortium to establish a registry for Alzheimer's disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
48. Kaplan EG, Weintraub S: The Boston Naming Test, Experimental Edition. Boston, Lea and Febiger, 1978.
49. Binetti G, Locascio JJ, Corkin S, Vonsattel JP, Growdon JH: Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol 2000;57:225-232.
50. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, Lea and Febiger, 1972.
51. Golden C: Stroop: Test de Colores y Palabras. Madrid, Tea Ediciones, 1994.
52. Stroop J: Studies of interference in serial verbal reaction. J Exp Psychol 1935;18:643-662.
53. Peña-Casanova J: Programa Integrado de Exploración Neuropsicológica: Test Barcelona (manual). Barcelona, Masson, 1990.
54. Partington JLR: Partington's pathways test. Psychol Serv Cent Bull 1949:11-20.
55. Raven JC: Test de Matrices Progresivas Escala General. Madrid, TEA Ediciones, 2001.
56. Yesavage JA: Geriatric Depression Scale. Psychopharmacol Bull 1988;24:709-711.
57. Teunisse S, Derix MM: Measurement of activities of daily living in patients with dementia living at home: development of a questionnaire (in Dutch). Tijdschr Gerontol Geriatr 1991;22:53-59.
58. Bohm P, Pena-Casanova J, Aguilar M, Hernandez G, Sol JM, Blesa R: Clinical validity and utility of the interview for deterioration of daily living in dementia for Spanish-speaking communities NORMACODEM group. Int Psychogeriatr 1998;10:261-270.
59. Reisberg B, Ferris SH, de Leon MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
60. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
61. Blanco-Vaca F, Arcelus R, Gonzalez-Sastre F, Ordonez-Llanos J, Queralto-Compano JM: Comparison of the Abbott Imx and a high-performance liquid chromatography method for measuring total plasma homocysteine. Clin Chem Lab Med 2000;38:327-329.
62. Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, Cavalli G: Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment. Mech Ageing Dev 2000;121:251-261.
63. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, Nygaard HA, Smith AD: Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol 2005;58:847-857.
64. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA: Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999;131:352-355.
65. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-1398.
66. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM: Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 2002;51:285-289.
67. den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM: Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003;126:170-175.
68. Dufouil C, Alperovitch A, Ducros V, Tzourio C: Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-221.
69. Russo C, Morabito F, Luise F, Piromalli A, Battaglia L, Vinci A, Trapani Lombardo V, de Marco V, Morabito P, Condino F, Quattrone A, Aguglia U: Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 2008;255:64-69.
70. Algaidi SA, Christie LA, Jenkinson AM, Whalley L, Riedel G, Platt B: Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp Neurol 2006;197:8-21.
71. Streck EL, Bavaresco CS, Netto CA, Wyse AT: Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav Brain Res 2004;153:377-381.